[1]石文杰,吴丽丽,张 丽,等.无抽搐电休克治疗对精神分裂症患者主观舒适度、个人和社会功能、泌乳素的影响[J].医学信息,2019,32(22):69-71.[doi:10.3969/j.issn.1006-1959.2019.22.022]
　SHI Wen-jie,WU Li-li,ZHANG Li,et al.Effect of Electroconvulsive Therapy without Convulsion on Subjective Comfort,Personal and Social Function,and Prolactin in Patients with Schizophrenia[J].Journal of Medical Information,2019,32(22):69-71.[doi:10.3969/j.issn.1006-1959.2019.22.022]
点击复制

无抽搐电休克治疗对精神分裂症患者主观舒适度、个人和社会功能、泌乳素的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年22期
页码:
69-71
栏目:
论著
出版日期:
2019-11-15

文章信息/Info

Title:
Effect of Electroconvulsive Therapy without Convulsion on Subjective Comfort,Personal and Social Function,and Prolactin in Patients with Schizophrenia
文章编号:
1006-1959（2019）22-0069-03
作者:
石文杰; 吴丽丽; 张 丽; 袁秀玉; 黄文忠; 尹岸民; 薛 永; 黄成兵
（江苏省淮安市第三人民医院精神科，江苏 淮安 223000）
Author(s):
SHI Wen-jie; WU Li-li; ZHANG Li; YUAN Xiu-yu; HUANG Wen-zhong; YIN An-min; XUE Yong; HUANG Cheng-bing
(Department of Psychiatry,the Third People's Hospital of Huai'an,Huai'an 223000,Jiangsu,China)
关键词:
无抽搐电休克; 精神分裂症; 个人和社会功能; 主观舒适度
Keywords:
No convulsion electroconvulsive; Schizophrenia; Personal and social function; Subjective comfort
分类号:
R749.3
DOI:
10.3969/j.issn.1006-1959.2019.22.022
文献标志码:
A
摘要:
目的 探讨无抽搐电休克治疗精神分裂症患者的泌乳素、主观舒适度、个人和社会功能的影响。方法 选择2017年6月~2019年5月淮安市第三人民医院收治的60例住院精神分裂症患者，采用随机数字表法分为研究组和对照组，各30例。对照组予以抗精神病药物治疗，研究组在药物治疗基础上予以无抽搐电休克治疗，比较两组治疗前后临床疗效、主观舒适度、个人和社会功能、泌乳素。结果 治疗后两组PANSS量表评分、SWN量表评分和PSP量表评分均较治疗前有改善，差异具有统计学意义（P＜0.05）；治疗后研究组PANSS量表评分和血清泌乳素水平低于对照组，而SWN量表评分、PSP量表评分高于对照组，差异具有统计学意义（P＜0.05）。结论 无抽搐电休克治疗精神分裂症有助于提高临床疗效，改善患者主观舒适度、个人和社会功能，减少泌乳素紊乱。
Abstract:
Objective To investigate the effects of non-convulsive electroconvulsive therapy on prolactin, subjective comfort, personal and social function in patients with schizophrenia. Methods 60 patients with schizophrenia admitted to the Third People's Hospital of Huai'an from June 2017 to May 2019 were randomly divided into study group and control group, 30 cases in each group. The control group was treated with antipsychotic drugs. The study group received no convulsion electroconvulsive therapy on the basis of drug treatment. The clinical efficacy, subjective comfort, personal and social functions, and prolactin were compared before and after treatment. Results After treatment, the PANSS scale, SWN scale and PSP scale scores of the two groups were improved compared with those before treatment,the difference was statistically significant (P<0.05). After treatment, the PANSS scale and serum prolactin levels in the study group were lower than those in the control group, while the SWN scale score and PSP scale score were higher than the control group,the difference was statistically significant (P<0.05).Conclusion The treatment of schizophrenia without electroconvulsive convulsions can improve clinical outcomes, improve subjective comfort, personal and social function, and reduce prolactin disorders.

参考文献/References:

[1]Tan BL,Lee SA,Lee J.Social cognitive interventions for people with schizophrenia:A systematic review[J].Asian J Psychiatr,2018(35):115-131. [2]van Liempt S,Dols A,Schouws S,et al.Comparison of social functioning in community-living older individuals with schizophrenia and bipolar disorder:a catchment area-based study[J].Int J Geriatr Psychiatry,2017,32(5):532-538. [3]吴勇,平军娇,杜宝国,等.非典型抗精神病药对精神分裂症患者骨代谢的影响[J].临床精神医学杂志,2017,27(4):272-274. [4]黄卓玮,王朔,高作惠.精神分裂症患者第2代抗精神病药治疗中主观感受及相关分析[J].临床精神医学杂志,2016,26(2):118-120. [5]胡靖,张家秀.精神分裂症认知测评及矫正对症状转归的影响[J].中国现代医学杂志,2019,29(6):100-104. [6]陶领钢,李启斌,于海,等.无抽搐电休克治疗对精神分裂症患者短时及瞬间记忆的影响[J].广西医学,2018,40(13):1427-1430. [7]Gan JL,Duan HF,Cheng ZX,et al.Neuroprotective Effect of Modified Electroconvulsive Therapy for Schizophrenia:A Proton Magnetic Resonance Spectroscopy Study[J].J Nerv Ment Dis, 2017,205(6):480-486. [8]Kaster TS,Daskalakis ZJ,Blumberger DM.Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia:A Large Retrospective Study[J].The Journal of Clinical Psychiatry,2017,78(4):e383-e389. [9]Isitt JJ,Nadipelli VR,Kouassi A,et al.Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone:An 8-week,randomized,double-blind, placebo-controlled,multicenter phase 3 study[J].Schizophr Res,2016,174(1-3):126-131. [10]唐伟,杨馥银,温娜,等.棕榈酸帕利哌酮长效针剂与利培酮治疗首次发病精神分裂症患者的随机对照研究[J].中华精神科杂志,2016,49(2):76-80. [11]李大奇,吕臻,况利,等.MECT联合rTMS治疗对偏执型精神分裂症患者认知功能的影响[J].重庆医学,2016,45(26):3631-3633,3637. [12]王碧馨,杜向东.精神分裂症患者高泌乳素血症与骨密度水平相关性研究进展[J].精神医学杂志,2018,31(5):388-391. [13]文启琴,郭伟坚,符卫仙,等.无抽搐电休克联合利培酮治疗精神分裂症的疗效及对血清泌乳素、认知功能的影响[J].中国医院用药评价与分析,2017,17(3):358-360.

相似文献/References:

[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
　ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Journal of Medical Information,2018,31(22):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
　ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Journal of Medical Information,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症 疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
　SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Journal of Medical Information,2018,31(22):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状 疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
　CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Journal of Medical Information,2018,31(22):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[5]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
　SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Journal of Medical Information,2022,35(22):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[6]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
　SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Journal of Medical Information,2018,31(22):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[7]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
　WU Jin-li.Clinical Application of Aripiprazole[J].Journal of Medical Information,2018,31(22):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[8]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
　SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Journal of Medical Information,2018,31(22):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[9]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
　LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Journal of Medical Information,2018,31(22):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
[10]韩佳睿,张 苹,张 媛.迟发性运动障碍与DNA甲基化之间关系的研究进展[J].医学信息,2018,31(20):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]
　HAN Jia-rui,ZHANG Ping,ZHANG Yuan.Advances in Research on the Relationship between Tardive Dyskinesia and DNA Methylation[J].Journal of Medical Information,2018,31(22):32.[doi:10.3969/j.issn.1006-1959.2018.20.010]

更新日期/Last Update: 2019-11-15